ERCC2 and melanoma: We identified the previously reported K751Q polymorphism (rs13181) that eliminates an ubiquitination site in the ERCC2 protein and is associated with greater risk of melanoma, acute myeloid leukemia, and Xeroderma Pigmentosum (42,43).